Рыночная капитализация Изменить Дата
AbbVie USD 508.97B 46.71B 2026-11
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
ALKERMES USD 7.43B 629M 2026-11
Amgen USD 247.94B 20.06B 2026-11
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.09T 40.33B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 4.52B 2.9B 2026-11
J&J USD 653.61B 42.25B 2026-09
Malin Corporation EUR 133.52M 29.05M 2026-08
Merck USD 375.59B 17.09B 2026-11
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.38B 1.96B 2026-11
Otsuka Holdings JPY 6.08T 213B 2026-09
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pfizer USD 165.12B 1.71B 2026-11
Vertex Pharmaceuticals USD 140.44B 7.93B 2026-11